Serum Resistin Concentrations are Higher in Human Obesity but Independent from Insulin Resistance

Abstract

Although obesity may be linked to resistin, the role of resistin in humans is still controversial. Conflicting results of the associations between resistin and BMI and measures of insulin resistance were reported. In view of the yet unexplained role of resistin in human obesity, the aim of this study was to examine correlations between serum resistin concentrations and the degree of human obesity and insulin sensitivity. For this purpose, we investigated 2 homogenous groups of obese and non obese humans, in whom the presence of obesity was the solely differentiating factor. The WHO definition of obesity was used. Study group consisted of 136 obese subjects (75 women and 61 men) and 48 non-obese controls (31 women, 17 men) aged 48.0±10.1, and 48.8±13.4 yrs, respectively.

Results: Obese subjects showed higher resistin concentrations than non obese controls (24.89±9.73 ng/mL, median 26.61 vs. 15.34±4.68 ng/mL, median 14.76, P<0.0001). Resistin concentrations correlated with BMI in the whole cohort (r=0.4296, P<0.0001), but not in obese and non-obese subjects separately (r=0.1418, P=0.0997; r=0.2712, P=0.0623, respectively). Moreover, serum resistin was not influenced by insulin resistance in either group examined.

Conclusion: Although concentrations of resistin differ between obese and non-obese humans, no relationship between resistin concentration and insulin resistance has been found. Correlations between resistin and BMI are present only in a mixed population but disappear in non obese and obese subjects when analyzed separately.

Key words

obesity - adipocytokines - hormones

References

• 1 Asano H, Izawa H, Nagata K. et al . Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population.  Diabetologia. 2010;  53 234-246
• 2 Azuma K, Katsukawa F, Oguchi S. et al . Correlation between serum resistin level and adiposity in obese individuals.  Obes Res. 2003;  11 997-1001
• 3 Butler J, Kalogeropoulos A, Georgiopoulou V. et al . Health ABC Study. Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study.  Arterioscler Thromb Vasc Biol. 2009;  29 1144-1149
• 4 Chen BH, Song Y, Ding EL. et al . Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts.  Diabetes Care. 2009;  32 329-334
• 5 Cizmecioglu FM, Etiler N, Ergen A. et al . Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.  Exp Clin Endocrinol Diabetes. 2009;  117 622-627
• 6 Degawa-Yamauchi M, Bovenkerk JE, Juliar BE. et al . Serum resistin (FIZZ3) protein is increased in obese humans.  J Clin Endocrinol Metab. 2003;  88 5452-5455
• 7 Fargnoli JL, Sun Q, Olenczuk D. et al . Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function.  Eur J Endocrinol. 2010;  162 281-288
• 8 Frankel DS, Vasan RS, D'Agostino Sr RB. et al . Resistin, adiponectin, and risk of heart failure the Framingham offspring study.  J Am Coll Cardiol. 2009;  53 754-762
• 9 Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
• 10 Fujinami A, Obayashi H, Ohta K. et al . Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes.  Clin Chim Acta. 2004;  339 57-63
• 11 Heilbronn LK, Rood J, Janderova L. et al . Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects.  J Clin Endocrinol Metab. 2004;  89 1844-1848
• 12 Hivert MF, Sullivan LM, Fox CS. et al . Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.  J Clin Endocrinol Metab. 2008;  93 3165-3172
• 13 Jain SH, Massaro JM, Hoffmann U. et al . Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study.  Diabetes Care. 2009;  32 903-908
• 14 Janke J, Engeli S, Gorzelniak K. et al . Resistin gene expression in human adipocytes is not related to insulin resistance.  Obes Res. 2002;  10 1-5
• 15 Juan CC, Au LC, Fang VS. et al . Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids.  Biochem Biophys Res Commun. 2001;  289 1328-1333
• 16 Le Lay S, Boucher J, Rey A. et al . Decreased resistin expression in mice with different sensitivities to a high-fat diet.  Biochem Biophys Res Commun. 2001;  289 564-567
• 17 Lee JH, Chan JL, Yiannakouris N. et al . Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.  J Clin Endocrinol Metab. 2003;  88 4848-4856
• 18 Luo Z, Zhang Y, Li F. et al . Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells.  Endocrine. 2009;  36 60-69
• 19 Matthews DR, Hosker JP, Rudenski AS. et al . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 20 McTernan CL, McTernan PG, Harte AL. et al . Resistin, central obesity, and type 2 diabetes.  Lancet. 2002;  359 46-47
• 21 McTernan PG, Fisher FM, Valsamakis G. et al . Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.  J Clin Endocrinol Metab. 2003;  88 6098-6106
• 22 McTernan PG, McTernan CL, Chetty R. et al . Increased resistin gene and protein expression in human abdominal adipose tissue.  J Clin Endocrinol Metab. 2002;  87 2407-2410
• 23 Muse ED, Lam TK, Scherer PE. et al . Hypothalamic resistin induces hepatic insulin resistance.  J Clin Invest. 2007;  117 1670-1678
• 24 Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle.  Biochem Biophys Res Commun. 2001;  285 561-564
• 25 Ohmori R, Momiyama Y, Kato R. et al . Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.  J Am Coll Cardiol. 2005;  46 379-380
• 26 Osawa H, Doi Y, Makino H. et al . Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.  Cardiovasc Diabetol. 2009;  18 60
• 27 Osawa H, Tabara Y, Kawamoto R. et al . Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.  Diabetes Care. 2007;  30 1501-1506
• 28 Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases.  Cell Mol Immunol. 2006;  3 29-34
• 29 Patel L, Buckels AC, Kinghorn IJ. et al . Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.  Biochem Biophys Res Commun. 2003;  300 472-476
• 30 Prins JB. Adipose tissue as an endocrine organ.  Best Pract Res Clin Endocrinol Metab. 2002;  16 639-651
• 31 Savage DB, Sewter CP, Klenk ES. et al . Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator activated receptor-gamma action in humans.  Diabetes. 2001;  50 2199-2202
• 32 Silha JV, Krsek M, Skrha JV. et al . Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.  Eur J Endocrinol. 2003;  149 331-335
• 33 Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture.  Cell. 1996;  87 377-389
• 34 Steppan CM, Bailey ST, Bhat S. et al . The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
• 35 Steppan CM, Brown EJ, Wright CM. et al . A family of tissue-specific resistin-like molecules.  Proc Natl Acad Sci USA. 2001;  98 502-506
• 36 Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance.  Trends Endocrinol Metab. 2002;  13 18-23
• 37 Vozarova de Court, Degawa-Yamauchi M, Considine RV. et al . High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.  Diabetes. 2004;  53 1279-1284
• 38 Walcher D, Hess K, Berger R. et al . Resistin: a newly identified chemokine for human CD4-positive lymphocytes.  Cardiovasc Res. 2010;  85 167-174
• 39 Wang H, Chen DY, Cao J. et al . High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome.  Chin Med Sci J. 2009;  24 161-166
• 40 Way JM, Görgün CZ, Tong Q. et al . Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.  J Biol Chem. 2001;  276 25651-25653
• 41 Won JC, Park CY, Lee WY. et al . Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance.  J Korean Med Sci. 2009;  24 695-700
• 42 Youn BS, Yu KY, Park HJ. et al . Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus.  J Clin Endocrinol Metab. 2004;  89 150-156

Correspondence